SYMBIOTEC PHARMALAB PRIVATE LTD

Overview

SYMBIOTEC PHARMALAB PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 43 active FDA Type II Drug Master Files, covering 16A-HYDROXY PREDNISOLONE (INTERMEDIATE); 17-a HYDROXYPROGESTERONE (INTERMEDIATE); BECLOMETHASONE DIPROPIONATE USP (MICRONIZED & NON-MICRONIZED); BETAMETHASONE ACETATE USP; BETAMETHASONE DIPROPIONATE; BETAMETHASONE SODIUM PHOSPHATE USP.

API / Drug Master Files

SYMBIOTEC PHARMALAB PRIVATE LTD holds 43 active (45 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DEXAMETHASONE SODIUM PHOSPHATE USPActive2025-09-15
• DEXAMETHASONE USPActive2023-03-29
• BETAMETHASONE SODIUM PHOSPHATE USPActive2022-09-09
• BETAMETHASONE ACETATE USPActive2022-07-21
• METHYLPREDNISOLONE USP (PROCESS 2)Active2020-11-05
• PREDNISOLONE USPActive2020-02-21
• ESTRADIOL HEMIHYDRATE USPActive2019-09-11
• DROSPIRENONE USPActive2018-08-30
• PREDNISOLONE ACETATE USPActive2018-06-04
• PROGESTERONE USPActive2018-04-03
• HYDROCORTISONE USPActive2017-01-12
• HYDROCORTISONE ACETATE USPActive2016-08-05
• HYDROXYPROGESTERONE CAPROATE USPActive2016-07-19
• TESTOSTERONE USP (MICRONIZED)Active2015-09-30
• 16A-HYDROXY PREDNISOLONE (INTERMEDIATE)Active2015-03-30

Showing 15 of 45 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SYMBIOTEC PHARMALAB PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.